Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib and Lapatinib in Advanced Cervical Cancer
NCT00430781Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of pazopanib, lapatinib in Cervical Cancer (CC), sponsored by GSK. Started Nov 2006; status: completed.
02
Drugs
pazopaniblapatinib
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00430781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430781.